drugset / Trial / NCT07845630
A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the Body
RandomizedCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to establish the bioequivalence of two different formulations of vicadrostat / empagliflozin in healthy male and female trial participants following oral administration.
Timeline
- Start
- 2026-10-14
- Primary completion
- 2026-12-11
- Completion
- 2026-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | — | Oral |
| Subject | Vicadrostat | Small molecule | — | Oral |
Indications
No indication recorded.